LU87233A1
(fr)
*
|
1988-06-07 |
1990-02-28 |
Pharlyse Sa |
Composition pharmaceutique a base d'un anti-inflammatoire non steroidien,son procede de preparation et son utilisation
|
DE3908047A1
(de)
*
|
1989-03-13 |
1990-09-20 |
Desitin Arzneimittel Gmbh |
Hochdisperse pharmazeutische zusammensetzung
|
FI96169C
(fi)
*
|
1989-07-10 |
1996-05-27 |
Eisai Co Ltd |
Menetelmä polyprenyyliyhdistettä sisältävän farmaseuttisen koostumuksen valmistamiseksi
|
WO1991002520A1
(en)
*
|
1989-08-17 |
1991-03-07 |
Cortecs Limited |
Pharmaceutical formulations
|
US5532002A
(en)
*
|
1989-08-17 |
1996-07-02 |
Cortecs Limited |
Gelatin pharmaceutical formulations
|
US5665384A
(en)
*
|
1990-04-06 |
1997-09-09 |
Rhone-Poulenc Rorer S.A. |
Oily capsules of ketoprofen
|
US5213807A
(en)
*
|
1990-05-03 |
1993-05-25 |
Chemburkar Pramod B |
Pharmaceutical composition containing ibuprofen and a prostaglandin
|
US5741502A
(en)
*
|
1990-07-19 |
1998-04-21 |
Helena Chemical Co. |
Homogeneous, essentially nonaqueous adjuvant compositions with buffering capability
|
USRE37313E1
(en)
*
|
1990-07-19 |
2001-08-07 |
Helena Chemical Company |
Homogeneous, essentially nonaqueous adjuvant compositions with buffering capability
|
US5580567A
(en)
*
|
1990-07-19 |
1996-12-03 |
Helena Chemical Company |
Homogeneous, essentially nonaqueous adjuvant compositions with buffering capability
|
US5178795A
(en)
*
|
1990-07-19 |
1993-01-12 |
Helena Chemical Company |
Homogeneous, essentially nonaqueous adjuvant compositions with buffering capability
|
US5393791A
(en)
*
|
1990-07-19 |
1995-02-28 |
Helena Chemical Company |
Homogeneous, essentially nonaqueous adjuvant compositions with buffering capability
|
US5110606A
(en)
*
|
1990-11-13 |
1992-05-05 |
Affinity Biotech, Inc. |
Non-aqueous microemulsions for drug delivery
|
US5552160A
(en)
*
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
US5688761A
(en)
*
|
1991-04-19 |
1997-11-18 |
Lds Technologies, Inc. |
Convertible microemulsion formulations
|
WO1992018147A1
(en)
*
|
1991-04-19 |
1992-10-29 |
Affinity Biotech, Inc. |
Convertible microemulsion formulations
|
JPH0525037A
(ja)
*
|
1991-07-01 |
1993-02-02 |
Upjohn Co:The |
経口投与酵素感受性腸溶製剤
|
US5273033A
(en)
*
|
1991-09-19 |
1993-12-28 |
Murray Electronics Associates Limited Partnership |
Electrical stimulation for treatment of osteoarthritis
|
JP3121080B2
(ja)
*
|
1991-12-19 |
2000-12-25 |
アール・ピー・シーラー コーポレイション |
カプセル封入用溶液
|
US5318960A
(en)
*
|
1992-06-03 |
1994-06-07 |
Frank Toppo |
System for transdermal delivery of pain relieving substances
|
HU209518B
(en)
*
|
1992-12-23 |
1994-06-28 |
Egyt Gyogyszervegyeszeti Gyar |
Process for production of free of skin damaging effect unguent preparation containing piroxicam
|
ATE192327T1
(de)
*
|
1993-03-24 |
2000-05-15 |
Collaborative Lab Inc |
Kosmetisches verabreichungssystem für salizylsäure und verfahren zur herstellung desselben
|
IT1263840B
(it)
*
|
1993-03-30 |
1996-09-04 |
Giuseppe Furiosi |
Formulazioni orali di ubidecarenone in forma di capsule
|
US20020099067A1
(en)
*
|
1993-07-08 |
2002-07-25 |
Ulrich Posanski |
Pharmaceutical compositions for sparingly soluble therapeutic agents
|
DE4322826A1
(de)
*
|
1993-07-08 |
1995-01-12 |
Galenik Labor Freiburg Gmbh |
Pharmazeutisches Präparat
|
JPH0725761A
(ja)
*
|
1993-07-09 |
1995-01-27 |
Kureha Chem Ind Co Ltd |
軟骨保護剤
|
GB2281697A
(en)
*
|
1993-09-14 |
1995-03-15 |
Euro Celtique Sa |
Laxative compositions in capsules
|
GB9325445D0
(en)
|
1993-12-13 |
1994-02-16 |
Cortecs Ltd |
Pharmaceutical formulations
|
US5567592A
(en)
*
|
1994-02-02 |
1996-10-22 |
Regents Of The University Of California |
Screening method for the identification of bioenhancers through the inhibition of P-glycoprotein transport in the gut of a mammal
|
JPH11507356A
(ja)
*
|
1995-06-07 |
1999-06-29 |
アブマックス,インコーポレイティド |
経口薬理化合物の生物有用性を高めるためのエッセンシャルオイルの利用
|
US5665386A
(en)
*
|
1995-06-07 |
1997-09-09 |
Avmax, Inc. |
Use of essential oils to increase bioavailability of oral pharmaceutical compounds
|
US5716928A
(en)
*
|
1995-06-07 |
1998-02-10 |
Avmax, Inc. |
Use of essential oils to increase bioavailability of oral pharmaceutical compounds
|
NZ512006A
(en)
*
|
1996-02-09 |
2005-05-27 |
Abbott Biotech Ltd |
Medical treatment with human TNF-alpha antibodies
|
ES2118033B1
(es)
*
|
1996-02-16 |
1999-07-01 |
Bial Ind Farmaceutica S A |
Formulacion farmaceutica antiinflamatoria.
|
DE69733752T2
(de)
*
|
1996-05-20 |
2006-06-01 |
G.D. Searle Llc, Chicago |
Arzneimittel enthaltend oxaprozin-natriumsalz,-kaliumsalz, oder-tris(hydroxymethyl)aminomethansalz
|
DE19646392A1
(de)
*
|
1996-11-11 |
1998-05-14 |
Lohmann Therapie Syst Lts |
Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
|
US6949264B1
(en)
|
1996-11-27 |
2005-09-27 |
Wm. Wrigley Jr. Company |
Nutraceuticals or nutritional supplements and method of making
|
GB9625589D0
(en)
|
1996-12-10 |
1997-01-29 |
Boots Co Plc |
Therapeutic agents
|
FR2764800B1
(fr)
*
|
1997-06-23 |
1999-09-10 |
Sanofi Sa |
Composition pharmaceutique solide contenant des derives de benzofuranne
|
US6013280A
(en)
*
|
1997-10-07 |
2000-01-11 |
Fuisz Technologies Ltd. |
Immediate release dosage forms containing microspheres
|
US5891845A
(en)
*
|
1997-11-21 |
1999-04-06 |
Fuisz Technologies Ltd. |
Drug delivery systems utilizing liquid crystal structures
|
US6294188B1
(en)
|
1998-07-09 |
2001-09-25 |
Aviana Biopharm Inc. |
Methods involving changing the constitutive and stimulated secretions of the local reproductive system of women
|
US6221391B1
(en)
*
|
1998-11-23 |
2001-04-24 |
Accucaps Industries Limited |
Self-emulsifying ibuprofen solution and soft gelatin capsule for use therewith
|
PL348193A1
(en)
*
|
1998-12-11 |
2002-05-06 |
Pharmasolutions |
Self-emulsifying compositions for drugs poorly soluble in water
|
US6586023B1
(en)
|
1998-12-15 |
2003-07-01 |
Wm. Wrigley Jr. Company |
Process for controlling release of active agents from a chewing gum coating and product thereof
|
US7163705B2
(en)
|
1998-12-15 |
2007-01-16 |
Wm. Wrigley Jr. Company |
Coated chewing gum product and method of making
|
US6531114B1
(en)
|
1999-04-06 |
2003-03-11 |
Wm. Wrigley Jr. Company |
Sildenafil citrate chewing gum formulations and methods of using the same
|
US6627234B1
(en)
|
1998-12-15 |
2003-09-30 |
Wm. Wrigley Jr. Company |
Method of producing active agent coated chewing gum products
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
US6267985B1
(en)
*
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US6294192B1
(en)
*
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US7935362B2
(en)
|
1999-04-06 |
2011-05-03 |
Wm. Wrigley Jr. Company |
Over-coated product including consumable center and medicament
|
US6773716B2
(en)
|
1999-04-06 |
2004-08-10 |
Wm. Wrigley Jr. Company |
Over-coated chewing gum formulations
|
US6322806B1
(en)
|
1999-04-06 |
2001-11-27 |
Wm. Wrigley Jr. Company |
Over-coated chewing gum formulations including tableted center
|
US6383471B1
(en)
*
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
US6355265B1
(en)
|
1999-04-06 |
2002-03-12 |
Wm. Wrigley Jr. Company |
Over-coated chewing gum formulations
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
US6458383B2
(en)
|
1999-08-17 |
2002-10-01 |
Lipocine, Inc. |
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
|
US6982281B1
(en)
*
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US6576224B1
(en)
*
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
US6663849B1
(en)
|
2000-09-01 |
2003-12-16 |
Wm. Wrigley Jr. Company |
Antacid chewing gum products coated with high viscosity materials
|
US6569472B1
(en)
|
2000-09-01 |
2003-05-27 |
Wm. Wrigley Jr. Company |
Coated chewing gum products containing antacid and method of making
|
US6645535B2
(en)
|
1999-09-02 |
2003-11-11 |
Wm. Wrigley Jr. Company |
Method of making coated chewing gum products containing various antacids
|
US6541048B2
(en)
|
1999-09-02 |
2003-04-01 |
Wm. Wrigley Jr. Company |
Coated chewing gum products containing an acid blocker and process of preparing
|
US9387168B2
(en)
|
1999-09-20 |
2016-07-12 |
Jack Barreca |
Chewing gum with tomatidine
|
AU3885201A
(en)
|
1999-09-20 |
2001-04-24 |
Mastercare |
Diet and weight control gum and sucker
|
US9253991B2
(en)
|
1999-09-20 |
2016-02-09 |
Jack Barreca |
Chewing gum with B vitamins
|
US7105172B1
(en)
*
|
1999-11-18 |
2006-09-12 |
Bolla John D |
Treatment of rosacea
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
US20030152636A1
(en)
*
|
2000-02-23 |
2003-08-14 |
Nanopharm Ag |
Method of treating cancer
|
SE0000774D0
(sv)
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
US6572900B1
(en)
|
2000-06-09 |
2003-06-03 |
Wm. Wrigley, Jr. Company |
Method for making coated chewing gum products including a high-intensity sweetener
|
US7115288B2
(en)
|
2000-06-09 |
2006-10-03 |
Wm. Wrigley Jr. Company |
Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
|
US6444241B1
(en)
|
2000-08-30 |
2002-09-03 |
Wm. Wrigley Jr. Company |
Caffeine coated chewing gum product and process of making
|
US6579545B2
(en)
|
2000-12-22 |
2003-06-17 |
Wm. Wrigley Jr. Company |
Coated chewing gum products containing an antigas agent
|
SE0100901D0
(sv)
*
|
2001-03-15 |
2001-03-15 |
Astrazeneca Ab |
New composition
|
US20020192161A1
(en)
*
|
2001-04-10 |
2002-12-19 |
Fahkreddin Jamali |
Animal model for evaluating analgesics
|
KR100425900B1
(ko)
*
|
2001-05-04 |
2004-04-03 |
대원제약주식회사 |
고농도 투명액상 이부프로펜 용액을 함유하는 속효성연질캅셀제
|
ITMI20011338A1
(it)
*
|
2001-06-26 |
2002-12-26 |
Farmatron Ltd |
Composizioni farmaceutiche orali a rilascio immediato del principio attivo
|
ITMI20011337A1
(it)
*
|
2001-06-26 |
2002-12-26 |
Farmatron Ltd |
Composizioni farmaceutiche orali a rilascio modificato del principio attivo
|
SE0102993D0
(sv)
|
2001-09-07 |
2001-09-07 |
Astrazeneca Ab |
New self emulsifying drug delivery system
|
JP4452970B2
(ja)
|
2002-03-27 |
2010-04-21 |
日本臓器製薬株式会社 |
ジクロフェナクナトリウム経口製剤
|
JP4500261B2
(ja)
|
2003-01-21 |
2010-07-14 |
千寿製薬株式会社 |
2−アミノ−3−(4−ブロモベンゾイル)フェニル酢酸含有水性液剤
|
US20040146537A1
(en)
*
|
2003-01-28 |
2004-07-29 |
Ramachandran Radhakrishnan |
Oily wax matrix suspension formulation comprising pharmacologically active agents
|
US20040162582A1
(en)
*
|
2003-02-13 |
2004-08-19 |
Hmt High Medical Technologies Ag |
Treatment of osteoarthritis
|
PL2279729T3
(pl)
*
|
2003-07-17 |
2017-02-28 |
Banner Life Sciences Llc |
Preparaty o kontrolowanym uwalnianiu
|
GB2407497A
(en)
*
|
2003-10-30 |
2005-05-04 |
John Anthony Walters |
Method and formulation for the rapid and stable taste-masking of insoluble pharmaceutically active compounds using a surfactant and a hydrocolloid
|
WO2005051347A2
(en)
*
|
2003-10-30 |
2005-06-09 |
Dianne Elizabeth Marshall |
A simple process and formulation for making taste- masked ibuprofen liquid preparations and similar good-tasting preparation of other pharmaceutically active or bitter, poor tasting compounds for the production of liquid preparations
|
WO2005070399A1
(en)
*
|
2004-01-09 |
2005-08-04 |
Wyeth |
Microemulsions for pharmaceutical compositions
|
US20050239747A1
(en)
*
|
2004-04-21 |
2005-10-27 |
Pharmaceutical Industry Technology And Development Center |
Compositions and methods of enhanced transdermal delivery of steroid compounds and preparation methods
|
US8129359B2
(en)
|
2004-06-04 |
2012-03-06 |
Ethicon, Inc. |
Composition and method for treating post-surgical pain
|
US8377906B2
(en)
|
2004-06-04 |
2013-02-19 |
Ethicon, Inc. |
Compositions and methods for preventing or reducing postoperative ileus and gastric stasis
|
EP2789342A1
(en)
|
2004-06-17 |
2014-10-15 |
Thrasos Innovation, Inc. |
TDF-related compounds and analogs thereof
|
WO2006021762A2
(en)
*
|
2004-08-23 |
2006-03-02 |
Fingadent International Ltd |
Bi-layered oral healthcare composition for pouch-like devices
|
US20060073173A1
(en)
*
|
2004-10-04 |
2006-04-06 |
Maria Banach |
Large-scale manufacturing process for the production of pharmaceutical compositions
|
CA2863125A1
(en)
|
2005-09-20 |
2007-03-29 |
Thrasos Innovation, Inc. |
Tdf-related compounds and analogs thereof
|
US20080260864A1
(en)
*
|
2005-10-21 |
2008-10-23 |
Medidermis Ltd. |
Topical Compositions for the Treatment of Depilation-Induced Irritation or Prevention Thereof
|
US20070287687A1
(en)
*
|
2006-06-13 |
2007-12-13 |
Primus Carolyn M |
Method for removing debris from tooth and bone surfaces using irrigation solution
|
IL184620A0
(en)
*
|
2007-07-15 |
2008-01-20 |
Can Fite Biopharma Ltd |
Composition for the treatment of inflammation
|
US20090130198A1
(en)
*
|
2007-11-21 |
2009-05-21 |
Innopharmax Inc. |
Pharmaceutical composition with enhanced bioavailability
|
JP2011510005A
(ja)
*
|
2008-01-18 |
2011-03-31 |
ダウ グローバル テクノロジーズ インコーポレイティド |
メトキシポリエチレングリコールを用いる難溶性活性物質の水溶解度増強方法
|
WO2010059628A1
(en)
*
|
2008-11-18 |
2010-05-27 |
Wisconsin Alumni Research Foundation |
Water-soluble formulations of resveratrol and uses thereof
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
US20110052679A1
(en)
|
2009-08-25 |
2011-03-03 |
Pharmaceutics International, Inc. |
Solid naproxen concentrates and related dosage forms
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
US8945627B2
(en)
|
2011-05-05 |
2015-02-03 |
Wisconsin Alumni Research Foundation |
Micelles for the solubilization of gossypol
|
WO2012159962A1
(en)
*
|
2011-05-20 |
2012-11-29 |
Aventis Pharma S.A. |
Pharmaceutical composition comprising ketoprofen
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
WO2016033549A2
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
US10596117B1
(en)
|
2014-12-31 |
2020-03-24 |
Eric Morrison |
Lipoleosomes as carriers for aromatic amide anesthetic compounds
|
US10561627B2
(en)
|
2014-12-31 |
2020-02-18 |
Eric Morrison |
Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
|
US11007161B1
(en)
|
2014-12-31 |
2021-05-18 |
Eric Morrison |
Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
KR20180126582A
(ko)
|
2016-04-01 |
2018-11-27 |
쎄러퓨틱스엠디, 인코퍼레이티드 |
스테로이드 호르몬 약제학적 조성물
|
US20180147215A1
(en)
|
2016-11-28 |
2018-05-31 |
Lipocine Inc. |
Oral testosterone undecanoate therapy
|
AT521139B1
(de)
*
|
2018-11-14 |
2019-11-15 |
Blum Gmbh Julius |
Führungssystem zur Führung eines bewegbar gelagerten Türflügels
|
CN114796100B
(zh)
*
|
2022-03-04 |
2023-09-22 |
中山大学 |
一种吡罗昔康凝胶贴膏剂及其制备方法
|